McAllen makes $1 million contribution to UTRGV School of Medicine

Translate to Spanish or other 102 languages!

The City of McAllen presented a check for $1 million to The UTRGV School of Medicine on Wednesday, Oct. 11, 2017, at the Medical Education Building on the Edinburg Campus. From left are McAllen City Commissioner Omar Quintanilla; Sen. Juan ‘Chuy’ Hinojosa (Texas District 20, D-McAllen); McAllen Mayor Jim Darling; Dr. John Krouse, UTRGV vice president for Medical Affairs and dean of the School of Medicine; and UTRGV President Guy Bailey. Photo by Roberto Hugo Gonzalez

Mega Doctor News

- Advertisement -

By Jennifer L. Berghom 

EDINBURG, TEXAS – OCT. 11, 2017 – The City of McAllen presented a $1 million check to The University of Texas Rio Grande Valley School of Medicine on Wednesday, in support of the school’s mission to educate students and residents and provide increased access to healthcare.

The payment is part of a memorandum of understanding UTRGV signed with McAllen and other Valley cities to support and ensure the success of the School of Medicine.

- Advertisement -

“We are grateful for the City of McAllen’s support of the School of Medicine,” said UTRGV President Guy Bailey. “These funds will support UTRGV and the School of Medicine in its mission to engage in innovative research, clinical care and the training of the next generation of physicians for the Rio Grande Valley.”

McAllen Mayor Jim Darling said the payment by the City of McAllen is its contribution to help improve the health and prosperity of the region.

“In order to help the entire Rio Grande Valley grow and improve – as a community, in business, and most importantly, in our health – then a strong and vibrant UTRGV School of Medicine is tantamount to help make that possible,” he said.

Dr. John H. Krouse, dean of the School of Medicine and vice president for Health Affairs, said McAllen’s support further solidifies the partnership between the UTRGV School of Medicine and the communities it serves.

- Advertisement -

“It will allow our faculty, medical residents and students to continue providing healthcare to those who otherwise would not have access to care,” Krouse said, “and it will help fund the innovative research that addresses the healthcare needs of the Valley community.”

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Moderna and Merck Report Positive Phase 3 Results for Personalized Cancer Therapy

Moderna and Merck have reached a major clinical milestone after their investigational individualized cancer therapy, combined with Merck’s Keytruda, produced positive results in a Phase 3 study involving patients with high-risk melanoma.

STHS Scores Fourth Consecutive 5-Star Rating for Diabetic Care

Diabetes remains one of the nation’s most pressing health challenges, with a disease once largely associated with older adults now affecting younger populations at an alarming rate.

STHS to Examine Back Pain in New “South Texas Healthy Living” Episode, Aug, 30th

Back pain is the most common pain condition reported by Americans, affecting nearly 65 million U.S. adults annually, with an estimated 16 million living with chronic symptoms, according to the Centers for Disease Control and Prevention (CDC).

Physicians Urge Updating Child Vaccinations Before School Starts

Texas physicians have an important message for parents as the new school year is about to begin: Ensure your children are current on all their necessary vaccinations. 
- Advertisement -